About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Slc47a1Gt(IST12634F2)Tigm
gene trap IST12634F2, Texas A&M Institute for Genomic Medicine
MGI:4100843
Summary 1 genotype
Jump to Allelic Composition Genetic Background Genotype ID
hm1
Slc47a1Gt(IST12634F2)Tigm/Slc47a1Gt(IST12634F2)Tigm B6.B6N-Slc47a1Gt(IST12634F2)Tigm MGI:5555046


Genotype
MGI:5555046
hm1
Allelic
Composition
Slc47a1Gt(IST12634F2)Tigm/Slc47a1Gt(IST12634F2)Tigm
Genetic
Background
B6.B6N-Slc47a1Gt(IST12634F2)Tigm
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Slc47a1Gt(IST12634F2)Tigm mutation (1 available); any Slc47a1 mutation (44 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
homeostasis/metabolism
• following paraquat administration, mice exhibit increased kidney degradation (including tubular dilatation, tubular cell vacuolation and tubular cell detachment from basement membrane) and liver damage (balloon hepatocytes and apoptotic necrotic cells) compared with wild-type mice
• mice exhibit a 6.9- and 3.4-fold accumulation of metformin in the liver and kidney compared with wild-type mice
• following paraquat intravenous administration, mice exhibit higher plasma, lung and renal paraquat concentrations compared with wild-type mice

growth/size/body

liver/biliary system
• liver damage following paraquat administration

renal/urinary system
• following paraquat administration





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
12/10/2024
MGI 6.24
The Jackson Laboratory